Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care.

Reference: Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy.

Muller SA, Gasperetti A, Bosman LP, Schmidt AF, Baas AF, Amin AS, Houweling AC, Wilde AAM, Compagnucci P, Targetti M, Casella M, Calò L, Tondo C, van der Harst P, Asselbergs FW, Peter van Tintelen J, Oerlemans MIFJ, Te Riele ASJM. J Am Coll Cardiol. 2023 May 9:S0735-1097(23)05543-2.

Go to PubMed